CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 1080819-1080932 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/68a7101a90454172c91785d8c352f776a82df5d4","sourcedb":"CORD-19","sourceid":"68a7101a90454172c91785d8c352f776a82df5d4","text":"The number of patients with a history of IS use or chemotherapy increased from 20% in Stage 1 to 100% in Stage 4.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T61934","span":{"begin":0,"end":113},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T61934","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T312","span":{"begin":0,"end":113},"obj":"Sentence"}],"attributes":[{"subj":"T312","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T584","span":{"begin":41,"end":43},"obj":"Disease"}],"attributes":[{"id":"A584","pred":"mondo_id","subj":"T584","obj":"http://purl.obolibrary.org/obo/MONDO_0007816"},{"id":"A585","pred":"mondo_id","subj":"T584","obj":"http://purl.obolibrary.org/obo/MONDO_0019399"},{"subj":"T584","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#939eec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#b8ec93"},{"id":"CORD-19-PD-MONDO","color":"#ec93d2"}]}]}}